ghk-cu + epithalon blend (50mg/10mg) – Pro Peptides GHK-CU – Kind Peptides
Description
Liao et al
BPC-157 is not registered as a drug in the EU or USA (clinical development PL 14736 halted at phase II in 2014) and has been on the WADA Prohibited List since 2022 in category S0 (non-approved substances)
Influence of cell quality on clinical outcome after autologous chondrocyte implantation
We want to see improvements
Potential Supportive Benefits May Include: This product does require refrigeration/cold pack
Combined with positive testimonials, they are emerging as tools worth exploring under professional supervision
